Welcome to Tekton Research, your premier partner for conducting Phase 1-4 clinical trials with unparalleled excellence. Our extensive investigator network covers key locations in Colorado, Georgia, Kansas, North Carolina, Oklahoma, Texas, and Virginia, showcasing exceptional expertise and unwavering commitment throughout the entire research process.
Backed by a team of accomplished principal investigators with diverse experience across therapeutic areas such as Endocrinology, Neurology, Dermatology, Rheumatology, and more, we successfully engage pediatric, adult, maternal, and elderly populations in our recruitment efforts.
Multi-Specialty
Our Site Network
We Manage the Study Lifecycle from Start to Finish
Tekton sites aim to be your first activated and enrolling sites. Our dedicated regulatory and contract teams collaborate with our clinical operations and recruitment departments, so we can efficiently activate our sites and begin screening upon green light.
Our clients have a single point of contact that oversees all start-up activities. Tekton Research utilizes metrics to ensure all action items remain on track to achieve target study timelines while keeping our clients informed about progress or barriers.
Tekton’s feasibility team and investigators are committed to providing reliable and timely feedback for site selection. Our sites can operate under a single confidentiality agreement or execute site-specific agreements based on client requirements. Our goal is to supply our clients with an enriched and accurate list of well-aligned, experienced sites that understand the indication and protocol complexities.
Tekton will propose PI’s and sites that are engaged, invested, and dedicated to meeting enrollment goals, providing a positive patient experience, and delivering quality data.
At Tekton, we begin considering the overall patient recruitment, engagement, and retention strategy once an initial feasibility questionnaire is received. Our patient recruitment department, operational team, and site staff work together, considering: patient populations, previous best practices, the complexities of the indication, inclusion and exclusion criteria, study design, and goals, to develop an efficient and effective patient recruitment strategy. A Tekton patient recruitment strategist collaborates with our clients and internal stakeholders to develop and execute these patient recruitment plans. We understand the importance of establishing a well-qualified patient pool as early as possible.
The Tekton team employs a variety of resources to pre-identify participants, including investigator databases, Tekton databases, community outreach and advocacy, local and centralized advertising campaigns, and AI technology. Our clinical site staff and dedicated recruitment specialists connect frequently with current study subjects as well as our Tekton proprietary databases, ensuring they remain interested, informed, and engaged. This communication improves the likelihood of future enrollment and dramatically improves patient retention for enrolling trials. Tekton collaborates with site staff, providers, and participants to actively involve patients in research, prioritizing their perspectives and needs, to provide the best patient experience possible.
Tekton sites adhere to SOPs and quality assurance initiatives in compliance with corporate and industry guidelines. Overseen by a dedicated QA team, Tekton conducts regular training sessions and updates within our quality management system.
Processes and practices are reviewed regularly to stay aligned with GCP, ICH, and FDA regulations. Being audit-ready at all times demonstrates Tekton’s commitment to excellence and regulatory compliance.
Tekton Research Announces Strategic Partnership with Dr. Alex Reish to Advance CNS Clinical Research
Understanding Influenza: The Vital Role of Research in Vaccine Development
Tekton Research Forms Strategic Partnership with Esteemed Family Medicine Specialist Dr. Corey Chamness in Tulsa, Oklahoma
Tekton Research and Dr. Martha Arambula Partner to Lead Pediatric Research Advancements in Yukon, OK
Tekton Research Appoints Jeffrey Zucker as Vice President of Neurology Operations
Tekton Research Expands Leadership Team with the Addition of Bruce Wakeman as Chief Commercial Officer
Our staff operates cohesively as a team, fostering collaboration and unity. We emphasize a collaborative relationship with our clients, ensuring that we work together seamlessly to achieve shared goals.
Kip championed bold initiatives to build a premier and sought-after site network for vaccine and specialty research. His business acumen led him to develop a strategic and unique business model that allows the company to grow organically and steadily with sustainable financial risk.
Corey’s early career included various financial leadership roles at GE Water & Process Technologies and Deloitte. He earned his bachelor’s degree in accounting from the University of South Carolina and is a Certified Public Accountant in the Commonwealth of Pennsylvania.
Corey is already working diligently to position Tekton for growth.
Bruce has had an extensive career in the pharmaceutical and clinical research industries, having recently served as Chief Commercial Officer at Emvenio Research. Prior to this role, he was Senior Vice President, Clinical Trials, Global Head of Commercial at Matrix Medical Network, and Vice President, Life Sciences Business Development, at Inteliquet. Bruce held senior roles at several other leading industry organizations, where he demonstrated proficiency in building strategic partnerships and driving revenue growth across different phases of drug development.
Bruce holds a Bachelor of Science degree in Business Management from the University of North Carolina, Wilmington. Today, he lives in St. Petersburg, Florida, with his wife, Lara, and three daughters.
Jeff resides in Philadelphia and holds a Bachelor of Science from Penn State University and a Masters of Psychology from Hahnemann University. His extensive experience spans multiple facets of the industry.
Jeff began his career as a psychotherapist, working with diverse populations in various settings. He transitioned to clinical research in 1996, managing a research facility focused on Neurology and Psychiatry in Princeton, NJ. At Eli Lilly, he established and nurtured site relationships and contributed to the development of CNS protocols to ensure their feasibility.
As a consultant, Jeff opened new sites, expanded existing ones, and managed a phase I unit. In the CRO space, he spent 13 years at Worldwide Clinical Trials, serving as SVP of Clinical Operations for 8 years. In this role, he provided oversight for Site Management, Rater Training, Feasibility, Patient Recruitment, and Decentralized Clinical Trials departments.
Alison’s passion is diabetes and metabolic disease. Alison is currently the Executive Director of Operations at Tekton Research overseeing all operations in five states with a heavy focus on vaccine research.
She now oversees Tekton’s business development team, feasibility operations, and strategic client relationships. Blaire serves as a central point of contact for all Tekton sites and clients and is determined to build win-win relationships with our clients and partners.
In 2020 and 2021, Taryn played a crucial role in managing COVID-19 vaccine trials, overseeing studies that contributed to vaccines receiving Emergency Use Authorization from the FDA. This work underscored Taryn's commitment to advancing medical research during critical times.
In 2023, [Your Name] transitioned into a Director of Quality Assurance position for a network of 23 sites. In this role, [Your Name] developed and implemented a comprehensive QA program, ensuring the highest standards of quality and compliance across the network.
"*" indicates required fields
All Rights Reserved. Site Designed By: